Ketamine Assisted Psychotherapy for Opioid Use Disorder

Recruiting now · Phase 1/Phase 2

Conditions studied: Opioid-use Disorder

In brief

This pilot clinical trial aims to assess the preliminary efficacy of ketamine as an adjunct for a mindfulness-based intervention for opioid use disorder.

Key facts

Study ID

NCT04892251

Run by

University of Utah

People needed

60

Starts

2021-05-20

Expected to finish

2024-05-30

Last updated by the study team

2023-07-05

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis of Opioid Use Disorder
• Receiving OUD treatment with a buprenorphine formulation

You may not qualify if…

• Previous experience with a mindfulness-based intervention program
• Pregnancy
• Any serious medical, mental, or cognitive issue that prevents successful participation in a mindfulness-based group treatment program
• Prior use of ketamine other than as prescribed by a physician
• Any of the following medical conditions
• Blood Vessel Disease Heart Valve Disease Heart Failure Class 2 or Above Heart Disease Pregnancy/Breastfeeding Arteriovenous Malformation History of Intracranial Bleeding or Stroke History of Seizures Hypoxia defined by current need for supplemental oxygen Liver Disease History of allergic reaction to Ketamine Dementia (moderate-severe) History of Psychotic Disorder, Bipolar Disorder, or Personality Disorder Dissociative Identity Disorder

Where it is running

• Center on Mindfulness and Integrative Health Intervention Development — Salt Lake City, Utah, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.